Skip to main content
Tyler Miller, MD, Pathology, Cleveland, OH

Tyler Eugene Miller MD PhD

Molecular Genetics, Anatomic Pathology, Clinical Pathology


Physician

Join to View Full Profile
  • 2103 Cornell RdCleveland, OH 44106

Dr. Miller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Miller is the Paul and Betsy Shiverick Professor of Immuno-Oncology and a physician-scientist at Case Western Reserve University School of Medicine and University Hospitals in Cleveland, OH. As a practicing pathologist and researcher, his work focuses on developing novel immunotherapy strategies for solid tumors, with a particular emphasis on brain cancers. Clinically, Dr. Miller is a Molecular Pathologist in the Genomic and Molecular Pathology at University Hospitals. Dr. Miller also leads a translational research lab that integrates advanced single-cell genomics, spatial transcriptomics and proteomics, and patient-derived tumor organoid modeling to better understand and target the immunosuppressive myeloid cells that contribute to immunotherapy resistance. His work has uncovered fundamental mechanisms of myeloid-driven immunosuppression in glioblastoma, paving the way for more effective immunotherapeutic approaches. Learn more at tymillerlab.org

Education & Training

  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 2018 - 2021
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 2018, MD, PhD

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2024 - 2026
  • TX State Medical License
    TX State Medical License 2024 - 2026
  • MA State Medical License
    MA State Medical License 2018 - 2024
  • Pathology - Clinical
    American Board of Pathology Pathology - Clinical

Publications & Presentations

PubMed

Press Mentions

  • Why Brain Cancer Is Often Resistant to Immunotherapy
    Why Brain Cancer Is Often Resistant to ImmunotherapyFebruary 26th, 2025

Grant Support

  • Targeting myeloid cells to increase efficacy of immunotherapy against brain tumors.CASE WESTERN RESERVE UNIVERSITY2023–2028
  • Targeting epigenetic regulation to disrupt glioma stem cell maintenance.National Cancer Institute2014–2018

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: